1. Home
  2. ORGN vs XGN Comparison

ORGN vs XGN Comparison

Compare ORGN & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Origin Materials Inc.

ORGN

Origin Materials Inc.

HOLD

Current Price

$0.16

Market Cap

109.4M

Sector

Industrials

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.42

Market Cap

110.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORGN
XGN
Founded
2008
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.4M
110.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ORGN
XGN
Price
$0.16
$3.42
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.17
AVG Volume (30 Days)
1.3M
484.4K
Earning Date
01-01-0001
04-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$49.18
$21.40
Revenue Next Year
$144.81
$14.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$2.67
52 Week High
$0.97
$12.23

Technical Indicators

Market Signals
Indicator
ORGN
XGN
Relative Strength Index (RSI) 35.45 24.56
Support Level $0.15 $3.15
Resistance Level $0.17 $3.37
Average True Range (ATR) 0.02 0.23
MACD 0.00 0.07
Stochastic Oscillator 19.11 9.30

Price Performance

Historical Comparison
ORGN
XGN

About ORGN Origin Materials Inc.

Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: